English  |  正體中文  |  简体中文  |  总笔数 :2856713  
造访人次 :  53620863    在线人数 :  1459
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"huang k h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 196-205 / 1033 (共104页)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-09-01T02:02:06Z Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:33Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:32Z Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial Lin C.-C.; Hsu C.-H.; Hour T.-C.; ANN-LII CHENG; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:19Z Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-08-31T02:35:30Z Endothelial dysfunction in primary aldosteronism Chen Z.-W.; Tsai C.-H.; CHIEN-TING PAN; Chou C.-H.; Liao C.-W.; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group
臺大學術典藏 2021-08-31T02:35:29Z Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow-Up Study With Tissue Doppler Imaging Chang Y.-Y.; Liao C.-W.; Tsai C.-H.; Chen C.-W.; CHIEN-TING PAN; Chen Z.-W.; Chen Y.-L.; Lin L.-C.; Chang Y.-R.; Wu V.-C.; Wu K.-D.; Hung C.-S.; Lin Y.-H.; Wu C.-H.; Chang H.-W.; Lian-Yu Lin M.D.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Chang C.-C.; Liao S.-C.; Yen R.-F.; on behalf of the TAIPAI Study Group*
臺大學術典藏 2021-08-24T08:01:28Z Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences CHIEH-KAI CHAN; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F.
臺大學術典藏 2021-08-24T08:01:28Z MiRNA-203 modulates aldosterone levels and cell proliferation by targeting wnt5a in aldosterone-producing adenomas Peng K.-Y.; Chang H.-M.; Lin Y.-F.; CHIEH-KAI CHAN; Chang C.-H.; Chueh S.-C.J.; Yang S.-Y.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.
臺大學術典藏 2021-08-24T08:01:28Z Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; CHIEH-KAI CHAN; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator
臺大學術典藏 2021-08-24T08:01:27Z Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism Liao H.-W.; Wang S.-M.; CHIEH-KAI CHAN; Lin Y.-H.; Lin P.-C.; Ho C.-H.; Liu Y.-C.; Chueh J.S.; Wu V.-C.; Lai T.-S.; Yang S.-Y.; Liu K.-L.; Chang C.-C.; Lee B.-C.; Huang K.-H.; Lin L.-Y.; Liao S.-C.; Yen R.-F.; Lu C.-C.; Er L.-K.; Hu Y.-H.; Chang C.-H.; Wu C.-H.; Tsai Y.-C.; Chueh S.-C.J.; Huang W.-C.; Chen Y.-Y.; Wu K.-D.

显示项目 196-205 / 1033 (共104页)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每页显示[10|25|50]项目